Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-013312
Filing Date
2019-11-05
Accepted
2019-11-05 15:22:23
Documents
69
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vericel9301910q.htm   iXBRL 10-Q 1519994
2 EXHIBIT 31.1 - CEO CERTIFICATION Q3 2019 ex311-ceocertification.htm EX-31.1 11870
3 EXHIBIT 31.2 - CFO CERTIFICATION Q3 2019 ex312-cfocertification.htm EX-31.2 11916
4 EXHIBIT 32.1 - CEO SOX CERTIFICATION 9.30.19 ex321-ceosoxcertificat.htm EX-32.1 7065
5 EXHIBIT 32.2 - CFO SOX CERTIFICATION 9.30.19 ex322-cfosoxcertificat.htm EX-32.2 7077
  Complete submission text file 0001628280-19-013312.txt   7060400

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT astm-20190930.xsd EX-101.SCH 40048
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT astm-20190930_cal.xml EX-101.CAL 96962
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT astm-20190930_def.xml EX-101.DEF 155486
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT astm-20190930_lab.xml EX-101.LAB 553990
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT astm-20190930_pre.xml EX-101.PRE 313161
14 EXTRACTED XBRL INSTANCE DOCUMENT vericel9301910q_htm.xml XML 1509181
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

EIN.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35280 | Film No.: 191193027
SIC: 2836 Biological Products, (No Diagnostic Substances)